nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—Asthenia—Chlorambucil—testicular cancer	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Infection—Dactinomycin—testicular cancer	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Cisplatin—testicular cancer	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Doxorubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Ifosfamide—testicular cancer	0.00193	0.00193	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Chlorambucil—testicular cancer	0.00191	0.00191	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Ifosfamide—testicular cancer	0.0019	0.0019	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Bleomycin—testicular cancer	0.00188	0.00188	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Epirubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Bleomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Ifosfamide—testicular cancer	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Methotrexate—testicular cancer	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Cisplatin—testicular cancer	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Dactinomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Chlorambucil—testicular cancer	0.00185	0.00185	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Vinblastine—testicular cancer	0.00182	0.00182	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Bleomycin—testicular cancer	0.00182	0.00182	CcSEcCtD
Sodium lauryl sulfate—Oedema—Ifosfamide—testicular cancer	0.00179	0.00179	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Ifosfamide—testicular cancer	0.00179	0.00179	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Cisplatin—testicular cancer	0.00178	0.00178	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Vinblastine—testicular cancer	0.00178	0.00178	CcSEcCtD
Sodium lauryl sulfate—Infection—Ifosfamide—testicular cancer	0.00177	0.00177	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Epirubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Doxorubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Ifosfamide—testicular cancer	0.00173	0.00173	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Chlorambucil—testicular cancer	0.00172	0.00172	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Ifosfamide—testicular cancer	0.0017	0.0017	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Dactinomycin—testicular cancer	0.00169	0.00169	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vinblastine—testicular cancer	0.00169	0.00169	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Dactinomycin—testicular cancer	0.00168	0.00168	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Ifosfamide—testicular cancer	0.00167	0.00167	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Bleomycin—testicular cancer	0.00166	0.00166	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Bleomycin—testicular cancer	0.00165	0.00165	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Irritability—Methotrexate—testicular cancer	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Vinblastine—testicular cancer	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Cisplatin—testicular cancer	0.00163	0.00163	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Doxorubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Sodium lauryl sulfate—Nausea—Chlorambucil—testicular cancer	0.0016	0.0016	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Ifosfamide—testicular cancer	0.0016	0.0016	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00159	0.00159	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Ifosfamide—testicular cancer	0.00159	0.00159	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vinblastine—testicular cancer	0.00157	0.00157	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Ifosfamide—testicular cancer	0.00155	0.00155	CcSEcCtD
Sodium lauryl sulfate—Headache—Vinblastine—testicular cancer	0.00155	0.00155	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Dactinomycin—testicular cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Dactinomycin—testicular cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Cisplatin—testicular cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Oedema—Cisplatin—testicular cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Bleomycin—testicular cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Infection—Cisplatin—testicular cancer	0.00153	0.00153	CcSEcCtD
Sodium lauryl sulfate—Constipation—Ifosfamide—testicular cancer	0.00153	0.00153	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Epirubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Cisplatin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Bleomycin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Etoposide—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Cisplatin—testicular cancer	0.00149	0.00149	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Bleomycin—testicular cancer	0.00148	0.00148	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vinblastine—testicular cancer	0.00147	0.00147	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Cisplatin—testicular cancer	0.00147	0.00147	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00146	0.00146	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Cisplatin—testicular cancer	0.00144	0.00144	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Dactinomycin—testicular cancer	0.00144	0.00144	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Ifosfamide—testicular cancer	0.00142	0.00142	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Ifosfamide—testicular cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Ifosfamide—testicular cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Etoposide—testicular cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Infection—Etoposide—testicular cancer	0.0014	0.0014	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Dactinomycin—testicular cancer	0.0014	0.0014	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Cisplatin—testicular cancer	0.00138	0.00138	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Etoposide—testicular cancer	0.00138	0.00138	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Cisplatin—testicular cancer	0.00137	0.00137	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Etoposide—testicular cancer	0.00136	0.00136	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Cisplatin—testicular cancer	0.00134	0.00134	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Dactinomycin—testicular cancer	0.00133	0.00133	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Bleomycin—testicular cancer	0.00133	0.00133	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Sodium lauryl sulfate—Rash—Bleomycin—testicular cancer	0.00132	0.00132	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Bleomycin—testicular cancer	0.00132	0.00132	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Ifosfamide—testicular cancer	0.00132	0.00132	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Methotrexate—testicular cancer	0.0013	0.0013	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Ifosfamide—testicular cancer	0.00128	0.00128	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Etoposide—testicular cancer	0.00127	0.00127	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Ifosfamide—testicular cancer	0.00126	0.00126	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Sodium lauryl sulfate—Nausea—Bleomycin—testicular cancer	0.00124	0.00124	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Dactinomycin—testicular cancer	0.00124	0.00124	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Sodium lauryl sulfate—Rash—Dactinomycin—testicular cancer	0.00123	0.00123	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Etoposide—testicular cancer	0.00123	0.00123	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Ifosfamide—testicular cancer	0.00122	0.00122	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Cisplatin—testicular cancer	0.00122	0.00122	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Sodium lauryl sulfate—Constipation—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Sodium lauryl sulfate—Nausea—Dactinomycin—testicular cancer	0.00116	0.00116	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Etoposide—testicular cancer	0.00115	0.00115	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Ifosfamide—testicular cancer	0.00114	0.00114	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Cisplatin—testicular cancer	0.00113	0.00113	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Sodium lauryl sulfate—Rash—Ifosfamide—testicular cancer	0.00113	0.00113	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Ifosfamide—testicular cancer	0.00112	0.00112	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Etoposide—testicular cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Etoposide—testicular cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Cisplatin—testicular cancer	0.0011	0.0011	CcSEcCtD
Sodium lauryl sulfate—Nausea—Ifosfamide—testicular cancer	0.00106	0.00106	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Cisplatin—testicular cancer	0.00105	0.00105	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Etoposide—testicular cancer	0.00101	0.00101	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Etoposide—testicular cancer	0.000998	0.000998	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—testicular cancer	0.000994	0.000994	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Cisplatin—testicular cancer	0.000979	0.000979	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Methotrexate—testicular cancer	0.000976	0.000976	CcSEcCtD
Sodium lauryl sulfate—Rash—Cisplatin—testicular cancer	0.000971	0.000971	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Cisplatin—testicular cancer	0.00097	0.00097	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Etoposide—testicular cancer	0.000965	0.000965	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—testicular cancer	0.000955	0.000955	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Etoposide—testicular cancer	0.000933	0.000933	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—testicular cancer	0.00092	0.00092	CcSEcCtD
Sodium lauryl sulfate—Nausea—Cisplatin—testicular cancer	0.000914	0.000914	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Methotrexate—testicular cancer	0.000897	0.000897	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Etoposide—testicular cancer	0.000897	0.000897	CcSEcCtD
Sodium lauryl sulfate—Rash—Etoposide—testicular cancer	0.000889	0.000889	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Etoposide—testicular cancer	0.000888	0.000888	CcSEcCtD
Sodium lauryl sulfate—Headache—Etoposide—testicular cancer	0.000884	0.000884	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Doxorubicin—testicular cancer	0.000883	0.000883	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Methotrexate—testicular cancer	0.000881	0.000881	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—testicular cancer	0.000878	0.000878	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—testicular cancer	0.000856	0.000856	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—testicular cancer	0.000851	0.000851	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Methotrexate—testicular cancer	0.000845	0.000845	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—testicular cancer	0.000839	0.000839	CcSEcCtD
Sodium lauryl sulfate—Infection—Methotrexate—testicular cancer	0.000839	0.000839	CcSEcCtD
Sodium lauryl sulfate—Nausea—Etoposide—testicular cancer	0.000838	0.000838	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Epirubicin—testicular cancer	0.000822	0.000822	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Methotrexate—testicular cancer	0.000817	0.000817	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Methotrexate—testicular cancer	0.000805	0.000805	CcSEcCtD
Sodium lauryl sulfate—Syncope—Doxorubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Doxorubicin—testicular cancer	0.000792	0.000792	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Methotrexate—testicular cancer	0.000789	0.000789	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—testicular cancer	0.000788	0.000788	CcSEcCtD
Sodium lauryl sulfate—Infection—Epirubicin—testicular cancer	0.000785	0.000785	CcSEcCtD
Sodium lauryl sulfate—Shock—Epirubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Doxorubicin—testicular cancer	0.000777	0.000777	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Epirubicin—testicular cancer	0.000772	0.000772	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—testicular cancer	0.000764	0.000764	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—testicular cancer	0.00076	0.00076	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Methotrexate—testicular cancer	0.000759	0.000759	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Epirubicin—testicular cancer	0.000754	0.000754	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Methotrexate—testicular cancer	0.000753	0.000753	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—testicular cancer	0.000739	0.000739	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Methotrexate—testicular cancer	0.000734	0.000734	CcSEcCtD
Sodium lauryl sulfate—Oedema—Doxorubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Methotrexate—testicular cancer	0.000728	0.000728	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—testicular cancer	0.000727	0.000727	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—testicular cancer	0.000714	0.000714	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—testicular cancer	0.00071	0.00071	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000707	0.000707	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Doxorubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000691	0.000691	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—testicular cancer	0.000684	0.000684	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Sodium lauryl sulfate—Constipation—Epirubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Methotrexate—testicular cancer	0.000671	0.000671	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Methotrexate—testicular cancer	0.000668	0.000668	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Methotrexate—testicular cancer	0.000668	0.000668	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—testicular cancer	0.000657	0.000657	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000646	0.000646	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Epirubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Sodium lauryl sulfate—Constipation—Doxorubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—testicular cancer	0.000625	0.000625	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—testicular cancer	0.000625	0.000625	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Methotrexate—testicular cancer	0.000622	0.000622	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Methotrexate—testicular cancer	0.000606	0.000606	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Methotrexate—testicular cancer	0.000598	0.000598	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—testicular cancer	0.000582	0.000582	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Methotrexate—testicular cancer	0.000578	0.000578	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Epirubicin—testicular cancer	0.000567	0.000567	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Epirubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Methotrexate—testicular cancer	0.000559	0.000559	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—testicular cancer	0.000541	0.000541	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—testicular cancer	0.000539	0.000539	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Methotrexate—testicular cancer	0.000537	0.000537	CcSEcCtD
Sodium lauryl sulfate—Rash—Methotrexate—testicular cancer	0.000533	0.000533	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Methotrexate—testicular cancer	0.000532	0.000532	CcSEcCtD
Sodium lauryl sulfate—Headache—Methotrexate—testicular cancer	0.000529	0.000529	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Doxorubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Epirubicin—testicular cancer	0.000523	0.000523	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Doxorubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Epirubicin—testicular cancer	0.000503	0.000503	CcSEcCtD
Sodium lauryl sulfate—Nausea—Methotrexate—testicular cancer	0.000502	0.000502	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Sodium lauryl sulfate—Rash—Epirubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Sodium lauryl sulfate—Headache—Epirubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Doxorubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Sodium lauryl sulfate—Nausea—Epirubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Doxorubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Sodium lauryl sulfate—Rash—Doxorubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Sodium lauryl sulfate—Nausea—Doxorubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
